Parallelly, using Kaplan‐Meier plotter online survival analyses in TNBC, we associate the high PRMT5 expression and poor patient prognosis in TNBC, as observed in a wide range of cancers (Stopa, Krebs, and Shechter 2015, 2041‐2059), including breast cancers.25, 45 We do not, however, observe elevated PRMT5 mRNA expression in TNBC from our breast cancer cohort nor from TCGA‐BRCA. The gene discussed is PRMT5; the disease is breast cancer.